Singapore BIOPHARMA PTE. LTD. announces exclusive distribution rights for StroVac® suspension for injection in Singapore.
StroVac® is an advanced bacterial lysate therapy designed for the prevention and treatment of recurrent urinary tract infections (rUTIs). It offers a non-antibiotic prevention approach, with clinically validated efficacy and up to a 95% recurrence-free rate.